Effects of intranasal administration of the peptide antagonist of type I vaniloid receptor (TRPV1) in the rodent central nervous system
Crossref DOI link: https://doi.org/10.1134/S0012496616050082
Published Online: 2016-11-08
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tishkina, A. O.
Mart’yanova, E. K.
Logashina, Yu. A.
Andreev, Ya. A.
Khaibullina, S. F.
Martynova, E. V.
Rizvanov, A. A.
Gulyaeva, N. V.
Grishin, E. V.
Text and Data Mining valid from 2016-09-01
Version of Record valid from 2016-09-01
Article History
Received: 8 June 2016
First Online: 8 November 2016